Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 3-year average of -10.32%, near the high end of its 3-year range (-1389.51%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-10.32%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-10.32%
5Y Avg
N/A
Market Cap
$10.02M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-312.48%
5Y Avg
-347.37%
Market Cap
$10.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.15M
Operating Margin
-76.66%
TTM Avg
-76.42%
3Y Avg
-167.47%
5Y Avg
-192.55%
Market Cap
$10.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.50M
Operating Margin
-11268.32%
TTM Avg
-39020.24%
3Y Avg
-22313.14%
5Y Avg
-16433.29%
Market Cap
$9.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.72M
Operating Margin
-289668.18%
TTM Avg
-144834.09%
3Y Avg
-74061.36%
5Y Avg
-50713.07%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | 0.00% | 0.00% | -10.32% | N/A |
| Valion Bio, Inc. (VBIO)vs › | $10.02M | 0.00% | 0.00% | -312.48% | -347.37% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifeward Ltd. (LFWD)vs › | $10.15M | -76.66% | -76.42% | -167.47% | -192.55% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.50M | -11268.32% | -39020.24% | -22313.14% | -16433.29% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polyrizon Ltd. (PLRZ)vs › | $10.38M | N/A | 0.00% | 0.00% | 0.00% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.72M | -289668.18% | -144834.09% | -74061.36% | -50713.07% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -34.94% | -189.60% | -1712.92% | -2140.33% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -92.88% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -1389.51% |
| 2023-12-31 | -1085.45% |
| 2023-09-30 | -593.88% |
